IYH tracks a cap-weighted index of pharmaceutical, biotechnology, health care services and equipment companies in the US.
Johnson & Johnson Advances Cancer and Immunology Treatments With Major Biotech Deals
J&J’s Rybrevant Faspro wins FDA priority review for advanced head and neck cancer treatment
Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation | JNJ Stock News
The Bull Case For AbbVie (ABBV) Could Change Following EU Approval Of Rinvoq For Vitiligo
Johnson & Johnson Stock (JNJ) Moved Down by 3.49% on Jul 30: Key Drivers Unveiled
UnitedHealth Group Incorporated (NYSE:UNH) Given Consensus Recommendation of "Moderate Buy" by Analysts